Crossmark

Changing epidemiology of SARS-CoV-2 positivity rates in a diverse population of children and adults during variant evolution and progressive vaccination eligibility in New York City

Crossref DOI link: https://doi.org/10.1186/s12879-025-11990-4

Published Online: 2025-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Velu, Priya D.

Thomas, Charlene

Rand, Sophie

Imada, Eddie

Zanettini, Claudio

Han, Jin-Young

Grinspan, Zachary

Abramson, Erika L.

Marchionni, Luigi

Cushing, Melissa M.

Acker, Karen P.
Funding

Funding for this research was provided by:

Weill Cornell Pediatric Pilot Award
License Information

Text and Data Mining valid from 2025-11-11

Version of Record valid from 2025-11-11
More Information

Article History

Received: 11 July 2025

Accepted: 17 October 2025

First Online: 11 November 2025

Declarations

:

: This retrospective clinical study was approved by the Weill Cornell Medicine Institutional Review Board under Protocol # 20-03021671. The IRB granted a waiver of informed consent and a HIPAA waiver in accordance with U.S. federal regulations (45 CFR 46.116(d)) given the retrospective nature of the study and minimal risk to participants. The study was conducted in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below